Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Preparation and characterization of methylene blue nanoparticles for Alzheimer's disease and other tauopathies

Preparation and characterization of methylene blue nanoparticles for Alzheimer's disease and other tauopathies

US Patent 10765755 · Granted Sep 8, 2020

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Nanoparticles and nanogel drug compositions for treatment of age-related macular2025
Ophthalmological formulations for the prevention of a coronavirus infection2024
Nanoparticles for treatment of posterior segment ocular diseases and conditions2023
Nanoparticles and nanogel drug compositions for treatment of age-related macular2022
Nanoparticles for treatment of posterior segment ocular diseases and conditions2021
Glutathione-coated nanoparticles for delivery of MKT-077 across the blood-brain 2021
Glutathione-coated nanoparticles for delivery of MKT-077 across the blood-brain 2021
Loteprednol etabonate nanoparticles in thermoreversible gels for enhanced therap2021
Nanoparticles for treatment of posterior segment ocular diseases and conditions2020
Glutathione-coated nanoparticles for delivery of MKT-077 across the blood-brain 2020
Glutathione-coated nanoparticles for delivery of MKT-077 across the blood-brain 2020
Nanoparticles in thermoreversible gels for enhanced therapeutics2020